Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
Is a |
Ciprofloxacin- and dexamethasone-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ciprofloxacin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexamethasone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucocorticoid hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
Has manufactured dose form |
Otic dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
Has manufactured dose form |
Ear suspension |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
Is a |
Product containing dexamethasone in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
Is a |
Product containing ciprofloxacin in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|